Listen now
Episode breakdown
Key takeaways
- International medical device companies must strategically structure their corporations, address business immigration, and protect intellectual property for successful U.S. market entry.
- Basic LLC formations through automated platforms can expose multi-million dollar startups to significant liability, necessitating tailored legal guidance.
- Securing O-1 founder visas and investor visas requires careful planning and tactical timing to avoid future immigration barriers.
- Companies should consider the legal and financial implications of state jurisdictions like Delaware versus Texas for corporate governance and shareholder control.
- Protecting service marks and other intellectual property from public database scraping and fraudulent filings is a critical ongoing task.
- The FDA regulatory process includes interactive reviews that companies should understand to avoid late-stage corrections to their corporate and product strategies.
- Be aware of the risks of AI voice cloning and deepfakes targeting executives, as well as the increasing prevalence of corporate filing scams.
When you develop a groundbreaking medical device, you assume the engineering and clinical data will carry you across the finish line. The legal landscape of U.S. market entry involves layers of corporate traps that most innovators completely overlook. In this episode of the Med Device Cyber Podcast, Christian and Trevor sit down with JJ Amell, the founder of Amell Law, to unpack the complex realities of international corporate structuring, business immigration, and intellectual property protection.
JJ shares his unique transition from building computers and working within his father's cardiology practice to guiding international medical technology firms through federal bureaucracy. The trio explores why setting up a basic LLC through automated online legal platforms leaves multi-million dollar startups exposed to catastrophic liability. They break down the tactical timing of securing O-1 founder visas and investor visas before state borders close behind you, and analyze the shifting corporate battleground between Delaware and Texas for control over majority shareholder decisions. The specifics may differ, but the challenge is the same: protecting what you've built. This conversation covers everything from Customs and Border Protection issues to defending service marks against public database scrapers.
Notable quotes
“The legal landscape of U.S. market entry involves layers of corporate traps that most innovators completely overlook.”
“Setting up a basic LLC through automated online legal platforms leaves multi-million dollar startups exposed to catastrophic liability.”
“Protecting what you've built covers everything from Customs and Border Protection issues to defending service marks against public database scrapers.”
“There's a shifting corporate battleground between Delaware and Texas for control over majority shareholder decisions.”
Frequently asked questions
Bring this work to your device
Need help with fda premarket cybersecurity?
Blue Goat Cyber delivers fda premarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.
FDA Premarket Cybersecurity ServicesMore on FDA Premarket Cybersecurity
Keep listening
-
Episode 69
Science Before Hype in MedTech Investing with Varun Turlapati of Chaanakya Capital
With Varun Turlapati
-
Episode 67
De-Risking Product Decisions in MedTech Startups with Brent Lavin of Ironwood MedTech Partners
With Brent Lavin
-
Episode 65
Why Clinical Trials Are the Most Expensive Capital Outlay for Startups with Rob Bedford, CEO of Franklyn Health
With Rob Bedford
-
Episode 62
Edge Cases, Alarm Fatigue, and Why AI Cannot Replace Clinical Judgment with Brandon Fertig, Senior Manager at Philips Healthcare
With Brandon Fertig